Active Health Foods, Inc. (OTCBB:AHFD) reached up 30% in morning trading to $.0039 with 10M shares traded. Active Health Foods, Inc. (AHFD), the maker of "Active XTM" 100% Organic Certified, 100% Natural, Kosher and Vegan Certified Energy Bars and "All Natural Flavors", a sparkling, flavored, sugar free beverage, announces that it has reached an agreement with UNFI, a leading independent national distributor of natural, organic and specialty foods and related products, including nutritional supplements, personal care items and organic produce in the United States. The agreement reached is that UNFI will represent and carry Active Health Foods, Inc.'s products, in particular the 100% Organic certified, 100% Natural, Kosher and Vegan certified Active XTM Energy Bars.
Yippy, Inc. (OTCQX:YIPI) Announces Subsidiary Acquires Macte! Inc. Based in Fort Myers, FL, Yippy, Inc. is a technology company specializing in the development of search, data normalization, and aggregation through application service environments for consumer and enterprise markets. Yippy's proprietary web-based product suites are deployed over cloud architecture and provide secure, redundant and maintained "Data as a Service" for businesses and education markets. The Company also operates several online web properties and educational reference portals. Yippy (YIPI) has been approved to trade on the OTCQX U.S., the intelligent marketplace for the best over-the-counter companies with the highest financial standards and superior information availability. Yippy, Inc. reported today that Yippy Labs, Inc., the Company's wholly owned British Columbian subsidiary, acquired Macte! Labs, Inc., a developer of dynamic toolbars and applications for both search and communication applications, located in Vancouver, British Columbia, Canada ("Macte"), pursuant to a share exchange agreement dated August 1, 2012..
American Superconductor Corporation (Nasdaq: AMSC) reached up 14.12% in morning trading to $4.04 with 300K shares traded. AMSC generates the ideas, technologies and solutions that meet the world's demand for smarter, cleaner ... better energy. Through its Windtec(TM) Solutions, AMSC enables manufacturers to launch best-in-class wind turbines quickly, effectively and profitably. Through its Gridtec(TM) Solutions, AMSC provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. The company's solutions are now powering gigawatts of renewable energy globally and enhancing the performance and reliability of power networks in more than a dozen countries. Founded in 1987, AMSC is headquartered near Boston, Massachusetts with operations in Asia, Australia, Europe and North America. AMSC (AMSC) today reported financial results for its first quarter of fiscal year 2012 ended June 30, 2012. Revenues for the first quarter of fiscal 2012 were $28.7 million, which compares with $9.1 million for the first quarter of fiscal 2011. The year-over-year increase was driven by strong growth in the company's Wind and Grid reporting segments.
Repligen Corporation (Nasdaq:RGEN) reached up 10.71% in morning trading to $4.34 with 150K shares traded. Repligen Corporation is a life sciences company that develops, manufactures and markets bioprocessing products for life sciences and biopharmaceutical manufacturing customers worldwide. They are a leading manufacturer of both native and recombinant forms of Protein A, critical reagents used in the manufacture of monoclonal antibodies, a type of biologic drug. They also supply several growth factor products used to increase cell culture productivity during the biomanufacturing process. In the burgeoning area of disposable biomanufacturing technologies, they have developed and market a series of OPUS™ (Open Platform User Specified) single-use chromatography columns used in the purification process for clinical-stage biologics. In addition to their core bioprocessing business, Repligen has a portfolio of clinical-stage partnering assets that includes two central nervous system (CNS) orphan drug candidates and a pancreatic imaging agent in Phase 3 development. Repligen Corporation (RGEN) today reported financial results for its second quarter and year-to-date period ended June 30, 2012. In addition, the Company announced that it will focus its corporate strategy and resources on the growth of its core bioprocessing business, which achieved record sales during the quarter. As a result of this defined strategic focus, the Company will seek a development and commercialization partner for its pancreatic imaging product candidate, RG1068.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at email@example.com.
Disclosure: PennyTrader.com and affiliates have been compensated twenty thousand dollars by the company previously for a four day YIPI investor awareness campaign in May 2012, and we are currently being compensated three thousand five hundred dollars by the company for a one day YIPI promotional email campaign.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE